HFRO Stock Recent News
HFRO LATEST HEADLINES
Only funds with yields over 8%, coverage higher than 90%, and trading at a discount are considered. Top lists of discount, yield, DxY, and DxYxZ are given. The top DxYxZ funds from this month's report are HFRO, BANX, and FPF.
Quantitative screens narrow down attractive closed-end funds for further investigation. "Quality" report focuses on funds with >100% distribution coverage to lower the risk of distribution cuts. Top lists provide shortlists for further research, not final buy or sell decisions.
Daily market opportunities can be enticing, but it's important to question why an opportunity is available in the first place. A fund that has outperformed its benchmarks is trading at a significant discount. Understanding the reasons behind the discount can help investors make informed decisions.
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. Top DxYxZ funds are HFRO, PFO and HNW.
Only funds with yields over 8%, coverage higher than 90%, and trading at a discount are considered. Top lists of discount, yield, DxY, and DxYxZ are given. The top DxY funds are HFRO, JSD, and JRO.
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given. Top DxYxZ funds are HFRO, HNW and BGX.
HFRO pays an attractive distribution yield and currently trades at more than a 30% discount to NAV. HFRO has been quite controversial in the past, but a new $100 million share repurchase program and reduced expense ratios are more shareholder-friendly. The HFRO litigation with Credit Suisse is still ongoing, but it appears the settlement received (if any) will be smaller than originally expected.
We can bank 50% more dividends when we look past the popular ETFs.
Only funds with yields over 8%, coverage higher than 90%, and trading at a discount are considered. Top lists of discount, yield, DxY, and DxYxZ are given.
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given.